Monroe Capital Corporatio... (MRCC)
| Bid | 7.23 |
| Market Cap | 157.08M |
| Revenue (ttm) | 42.99M |
| Net Income (ttm) | 9.7M |
| EPS (ttm) | 0.45 |
| PE Ratio (ttm) | 16.11 |
| Forward PE | 7.19 |
| Analyst | Hold |
| Ask | 8.2 |
| Volume | 28,995 |
| Avg. Volume (20D) | 68,883 |
| Open | 7.20 |
| Previous Close | 7.22 |
| Day's Range | 7.17 - 7.39 |
| 52-Week Range | 6.55 - 8.85 |
| Beta | 0.97 |
About MRCC
Monroe Capital Corporation is a business development company specializing in customized financing solutions in senior, unitranche and junior secured debt, subordinated debt financing and to a lesser extent, unsecured debt and equity, including equity co-investments in preferred and common stock and warrants. It also provides financing primarily to leveraged buyouts in lower middle-market companies. It focuses to invest in the United States and Ca...
Analyst Forecast
According to 1 analyst ratings, the average rating for MRCC stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 10.34% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago · businesswire.com
Monroe Capital Supports Olympus Partners' Acquisition of PAI PharmaCHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) announced it acted as joint lead arranger on the funding of a senior credit facility to support the acquisition of PAI Pharma (“PAI”) by Olympus...
1 month ago · businesswire.com
Monroe Capital Supports Battery Ventures' Investment in Signiant, Inc.CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the investment in Signia...
